leadf
logo-loader
viewBioLargo, Inc.
(
OTCQB:BLGO
)

BioLargo says interest is 'extreme' in its Clyraguard spray that dispels the coronavirus

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive that Clyraguard, a spray developed by its subsidiary Clyra Medical Technologies, was shown to cause complete inactivation of the coronavirus in lab testing.

Calvert says Clyraguard is a personal protective spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment from the coronavirus.

Quick facts: BioLargo, Inc.

Follow
OTCQB:BLGO

Price: 0.18 USD

Market Cap: $41.07 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BioLargo says its PFAS water testing program has been met with 'impressive...

BioLargo, Inc's Randy Moore and Tonya Chandler joined Proactive to speak about the group's new service testing customer water to detect per- and polyfluoroalkyl substances (PFAS) contamination levels. The group say the program offers 'peace of mind and proof of concept' to customers who need...

5 days, 22 hours ago

2 min read